Novavax Financial Overview
Novavax's market cap is currently $1.06B. The company's EPS TTM is $-1.25; its P/E ratio is 3.69; Novavax is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
